507
Participants
Start Date
October 31, 2014
Primary Completion Date
December 31, 2015
Study Completion Date
July 31, 2016
SAR342434
SAR342434 100 U/mL (dose range of 1 Unit to 80 Units) self-administered by deep subcutaneous (SC) injection, immediately (within 5-10 minutes) before meal intake. Dose adjusted to achieve a 2-hour post prandial plasma glucose (PPG) in range of 6.7 to 8.9 mmol/L (120 to 160 mg/dL) while avoiding hypoglycemia.
Humalog
Humalog 100 U/mL (dose range of 1 unit to 60 units) self-administered by deep SC injection, immediately (within 5-10 minutes) before meal intake. Dose adjusted to achieve a 2 hour PPG in range of 6.7 to 8.9 mmol/L (120 to 160 mg/dL) while avoiding hypoglycaemia.
Insulin glargine HOE901
Insulin glargine 100 U/mL injected QD subcutaneously consistent with the local label. Doses adjusted to achieve glycemic target for fasting, preprandial plasma glucose (SMPG) between 4.4 to 7.2 mmol/L (80 to 130 mg/dL) without hypoglycemia.
Investigational Site Number 348002, Budapest
Investigational Site Number 348005, Budapest
Investigational Site Number 348003, Budapest
Investigational Site Number 348011, Budapest
Investigational Site Number 348010, Budapest
Investigational Site Number 348001, Budapest
Investigational Site Number 348007, Debrecen
Investigational Site Number 724001, Cáceres
Investigational Site Number 276001, Berlin
Investigational Site Number 840059, Mineola
Investigational Site Number 276007, Potsdam
Investigational Site Number 724002, A Coruña
Investigational Site Number 840014, Rockville
Investigational Site Number 840038, Baltimore
Investigational Site Number 840011, Chesapeake
Investigational Site Number 276003, Neumünster
Investigational Site Number 724004, Lleida
Investigational Site Number 840030, Burlington
Investigational Site Number 840051, Greenville
Investigational Site Number 840062, Wilmington
Investigational Site Number 724005, Málaga
Investigational Site Number 840045, Roswell
Investigational Site Number 276006, Hanover
Investigational Site Number 840036, Atlanta
Investigational Site Number 840061, Miami Lakes
Investigational Site Number 840057, Miami Lakes
Investigational Site Number 840050, Miami
Investigational Site Number 840013, North Miami Beach
Investigational Site Number 840042, Miami
Investigational Site Number 840031, Port Charlotte
Investigational Site Number 840005, Bradenton
Investigational Site Number 250003, Montpellier
Investigational Site Number 840006, New Port Richey
Investigational Site Number 276004, Dortmund
Investigational Site Number 840018, Gallipolis
Investigational Site Number 840004, Des Moines
Investigational Site Number 250001, Vandœuvre-lès-Nancy
Investigational Site Number 840007, Dakota Dunes
Investigational Site Number 840027, Rapid City
Investigational Site Number 840060, Great Falls
Investigational Site Number 840012, McHenry
Investigational Site Number 840019, Chicago
Investigational Site Number 840033, Chicago
Investigational Site Number 840026, Omaha
Investigational Site Number 840040, Omaha
Investigational Site Number 276002, Heidelberg
Investigational Site Number 840021, Metairie
Investigational Site Number 840043, Marrero
Investigational Site Number 840041, Dallas
Investigational Site Number 840029, Dallas
Investigational Site Number 840034, Dallas
Investigational Site Number 840002, Houston
Investigational Site Number 250005, Mantes-la-Jolie
Investigational Site Number 840003, Denver
Investigational Site Number 840037, Denver
Investigational Site Number 840020, Idaho Falls
Investigational Site Number 840049, Tucson
Investigational Site Number 840015, Albuquerque
Investigational Site Number 840054, Albuquerque
Investigational Site Number 840016, Bell Gardens
Investigational Site Number 250002, Corbeil-Essonnes
Investigational Site Number 840048, Chula Vista
Investigational Site Number 840028, La Jolla
Investigational Site Number 276005, Sulzbach-Rosenberg
Investigational Site Number 840022, Ventura
Investigational Site Number 840039, Fresno
Investigational Site Number 840046, Concord
Investigational Site Number 643003, Moscow
Investigational Site Number 643004, Saint Petersburg
Investigational Site Number 643001, Saint Petersburg
Investigational Site Number 643005, Saint Petersburg
Investigational Site Number 643002, Saratov
Investigational Site Number 643006, Samara
Investigational Site Number 643007, Tomsk
Investigational Site Number 840023, Tacoma
Investigational Site Number 840009, Milwaukee
Investigational Site Number 276008, Pirna
Investigational Site Number 392006, Chūōku
Investigational Site Number 392003, Higashiosaka-Shi
Investigational Site Number 392004, Izumisano
Investigational Site Number 392005, Kamakura-Shi
Investigational Site Number 392001, Shinjuku-Ku
Investigational Site Number 392002, Yamato-Shi
Investigational Site Number 616005, Krakow
Investigational Site Number 616001, Poznan
Investigational Site Number 616003, Szczecin
Investigational Site Number 616002, Warsaw
Investigational Site Number 616004, Zabrze
Investigational Site Number 724003, Sabadell
Lead Sponsor
Sanofi
INDUSTRY